Jo Armes, PhD, MSc, BSc, RGN, University of Surrey, Surrey, UK, discusses a study investigating the incidence of cancer in the prison population in the UK, as well as differences in experiences and clinical outcomes compared to the general population. The study found that incidence rates are similar in prison as in the general population, but certain cancers in men, such as colorectal and genitourinary cancers, are less likely to be diagnosed. Data also showed that patients in prison are less likely to receive surgical treatment and overall have worse survival outcomes than the general population. Key barriers to diagnosis include difficulty in accessing GP appointments and the presence of prison officers in appointments making it more difficult to discuss sensitive issues with the healthcare staff. It is also difficult for patients in prison to contact their oncologist and discuss their treatment outside of face-to-face visits. This interview took place at the UK Oncology Nursing Society (UKONS) 2022 Annual Conference in Belfast, UK.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
